2007
DOI: 10.1016/j.plefa.2007.10.014
|View full text |Cite
|
Sign up to set email alerts
|

n-3 Fatty acids and cardiovascular disease: Actions and molecular mechanisms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
43
0
2

Year Published

2009
2009
2018
2018

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 60 publications
(45 citation statements)
references
References 105 publications
0
43
0
2
Order By: Relevance
“…Also, in animal models, n3 PUFA supplementation has been shown to enhance ( 72 ) or prevent the reduction in ERG a-and b-wave amplitudes after transient ischemia ( 73,74 ). Dietary n3 PUFAs have also been shown to be effective in suppressing infl ammation and in reducing the incidence of arteriosclerosis and heart failure by lowering plasma triglycerides and blood pressure ( 75,76 ). Thus, we evaluated which of the LC-PUFAs are metabolically active precursors for the synthesis of VLC-PUFA using cell cultures as a fi rst step to eventually determine whether dietary supplementation of these FAs could provide benefi cial effects to STGD3 patients, as has been shown for AMD patients in some of the Age-Related Eye Disease Study (AREDS) studies ( 37,39 ).…”
Section: Discussionmentioning
confidence: 99%
“…Also, in animal models, n3 PUFA supplementation has been shown to enhance ( 72 ) or prevent the reduction in ERG a-and b-wave amplitudes after transient ischemia ( 73,74 ). Dietary n3 PUFAs have also been shown to be effective in suppressing infl ammation and in reducing the incidence of arteriosclerosis and heart failure by lowering plasma triglycerides and blood pressure ( 75,76 ). Thus, we evaluated which of the LC-PUFAs are metabolically active precursors for the synthesis of VLC-PUFA using cell cultures as a fi rst step to eventually determine whether dietary supplementation of these FAs could provide benefi cial effects to STGD3 patients, as has been shown for AMD patients in some of the Age-Related Eye Disease Study (AREDS) studies ( 37,39 ).…”
Section: Discussionmentioning
confidence: 99%
“…Fish are the primary source in the human diet of n-3 long-chain polyunsaturated fatty 51 acids (LC-PUFA), which have been demonstrated to promote cardiovascular health and 52 immune function, and protect against neurological and inflammatory conditions 53 (Calder, 2007;Calon and Cole, 2007;Torrejon et al, 2007). With aquaculture 54 increasing its contribution to the overall supply of fish in the human food basket (FAO,55 2009), considerable efforts have been made to elucidate the biochemical and molecular 56 mechanisms controlling the biosynthesis of LC-PUFA in fish (Tocher, 2003).…”
Section: Introduction 50mentioning
confidence: 99%
“…Clinical studies have demonstrated that the stability of atherosclerotic plaques could explain the reduction in non-fatal and fatal cardiovascular events associated with increased n-3 PUFA intake 13) . These effects might involve changes in triglyceride blood levels and lipoproteins leading to a less atherogenic profile by slowing down the progression of atherosclerosis 14) . Recently, it was demonstrated that fish oil reduced the expression of P-selectin and vascular and intracellular adhesion molecule (VCAM-1 and ICAM-1), which may explain the prevention of atherosclerosis development 15) .…”
Section: Introductionmentioning
confidence: 99%